Ocugen (OCGN) Change in Cash (2014 - 2026)
Ocugen (OCGN) reported Change in Cash of $13.3 million for Q1 2026, up 164.15% on a YoY basis from $5.0 million in Q1 2025, and up 194.96% quarter-over-quarter from -$14.0 million in Q4 2025.
Ocugen (OCGN) Change in Cash (2014 - 2026) Analysis & Trends
Ocugen has reported Change in Cash for 13 years, with the latest figure at $13.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 164.15% year-over-year to $13.3 million; the trailing twelve-month figure through Mar 2026 stood at -$5.9 million (down 150.59% YoY), and the FY2025 full-year result was -$39.9 million, down 306.28% from the prior year.
- Change in Cash for Q1 2026 stood at $13.3 million, up from -$14.0 million in the prior quarter.
- The five-year high for Change in Cash was $34.8 million in Q1 2022, with the low at -$24.0 million in Q4 2022.
- Historically, Change in Cash has averaged -$3.7 million across 5 years, with a median of -$10.8 million in 2025.
- The largest YoY upside for Change in Cash was 241.42% in 2024 against a maximum downside of 547.43% in 2024.
- Ocugen's Change in Cash stood at -$24.0 million in 2022, then soared by 41.7% to -$14.0 million in 2023, then surged by 241.42% to $19.8 million in 2024, then sank by 170.59% to -$14.0 million in 2025, then jumped by 194.96% to $13.3 million in 2026.
- The last three Change in Cash figures came in at $13.3 million (Q1 2026), -$14.0 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 13.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.29 Mn |
| Dec 31, 2025 | -13.99 Mn |
| Sep 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | -10.79 Mn |
| Mar 31, 2025 | -20.71 Mn |
| Dec 31, 2024 | 19.82 Mn |
| Sep 30, 2024 | 23.00 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Mar 31, 2024 | -13.09 Mn |
| Dec 31, 2023 | -14.02 Mn |
| Sep 30, 2023 | -17.10 Mn |
| Jun 30, 2023 | 2.32 Mn |
| Mar 31, 2023 | -9.30 Mn |
| Dec 31, 2022 | -24.04 Mn |
| Sep 30, 2022 | -13.40 Mn |
| Jun 30, 2022 | -14.92 Mn |
| Mar 31, 2022 | 34.81 Mn |
| Dec 31, 2021 | -12.39 Mn |
| Sep 30, 2021 | -8.29 Mn |
| Jun 30, 2021 | 70.85 Mn |